Mercury Systems Inc (NASDAQ: MRCY) has reported a loss for its fourth fiscal quarter (ending June 30) of $-0.19 versus a loss $-0.15 for the same period a year ago. E.P.S. were $-2.38 for the […]
Marker Therapeutics Inc (NASDAQ: MRKR) stock closed at $3.39 on 8/13/24 after a major decline of -11.3%. However, below average trading volume at 79% of normal accompanied the decline. The stock has been strong relative […]
Hennessy Advisors Inc (NASDAQ: HNNA) stock enjoyed a major increase of 23.1% on 8/13/24. The shares closed at $11.07. Moreover, trading volume in this advance was exceptionally high at 1187% of normal. The stock has […]
FreightCar America Inc (NASDAQ: RAIL) stock closed at $4.17 on 8/13/24 after a major increase of 16.8%. Moreover, exceptionally high trading volume at 1385% of normal accompanied the advance. The stock has risen 33.7% during […]
For its second fiscal quarter (ending June 30), Digimarc Corp (NASDAQ: DMRC) has reported E.P.S. of $-0.43 compared to $-0.53 a year ago. E.P.S. were $-1.98 for the latest four quarters through June 30 versus […]
XOMA Corp (NASDAQ: XOMA) stock closed at $26.46 on 8/13/24 after a major increase of 14.4%. NORMAL trading volume accompanied the advance. The stock has risen 12.4% during the last week and has been exceptionally […]
Univest Financial Corp (NASDAQ: UVSP). Notable positive changes in fundamentals have recently occurred: the consensus estimate for December, 2025 increased significantly, the consensus estimate for December, 2024 increased significantly, and significant quarterly earnings acceleration occurred. […]
Surmodics Inc (NASDAQ: SRDX). Extremely significant negative changes in investment behavior have recently occurred: negative upside/downside volume developed, its shorter term price trend turned down, and the stock fell on very heavy volume. Marginal negative […]
Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 11.2% on 8/13/24. The shares closed at $6.04. However, below average trading volume at 82% of normal accompanied the advance. The stock has been […]
Recent Price Action On 8/13/24, Catalyst Biosciences Inc (NASDAQ: CBIO) stock declined by -2.5%, closing at $10.40. However, trading volume in this decline was exceptionally low at 46% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research